Abstract

Benign prostatic hyperplasia (BPH) is the most common disease of the lower urinary tract in men. The prevalence increases continuously with increasing age and achronic progressive course is to be expected. In order to reduce the morbidity of affected patients and to improve their quality of life, the expert panel Benign Prostatic Hyperplasia (BPH) of the German Society of Urology (DGU) has written anew version of the evidence-based "S2e guideline on the diagnosis and treatment of BPH". Using acurrent patient case, the contents of the new S2e guideline are illustrated, from diagnosis to the decision-making process for asuitable treatment choice. The case presented here shows the possible complexity and difficulty that can arise in the diagnosis of BPH, the need for further diagnostic steps and the finding of asuitable therapy in order to fulfill the patient's wishes, if possible.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call